Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -0.31% is 104% below its 5-year average of 8.71%, near the high end of its 5-year range (-78.99%–16.01%).
111.76% below its 12-month average of 2.64%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -18.61%.
OPERATING MARGIN
-0.31%
OPERATING MARGIN AVG TTM
2.64%
OPERATING MARGIN AVG 3Y
8.44%
OPERATING MARGIN AVG 5Y
8.71%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-111.76%
CURRENT VS 3Y AVG
-103.67%
CURRENT VS 5Y AVG
-103.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
AdaptHealth Corp.
Market Cap
$780.95M
Operating Margin
-0.31%
TTM Avg
2.64%
3Y Avg
8.44%
5Y Avg
8.71%
Market Cap
$776.24M
Operating Margin
-29.28%
TTM Avg
-127.46%
3Y Avg
-26333.62%
5Y Avg
-23986.43%
Market Cap
$775.72M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$786.48M
Operating Margin
-21.60%
TTM Avg
-15.14%
3Y Avg
-11.45%
5Y Avg
-3.99%
Market Cap
$774.32M
Operating Margin
-4974.74%
TTM Avg
-2487.37%
3Y Avg
-2487.37%
5Y Avg
-2487.37%
Market Cap
$767.46M
Operating Margin
-123601.69%
TTM Avg
-69568.65%
3Y Avg
-35191.57%
5Y Avg
-23714.64%
Market Cap
$749.55M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-6934.80%
5Y Avg
-9894.67%
Market Cap
$819.44M
Operating Margin
9.86%
TTM Avg
12.61%
3Y Avg
-6.26%
5Y Avg
-239.99%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AdaptHealth Corp. (AHCO) | $780.95M | -0.31% | 2.64% | 8.44% | 8.71% |
| Geron Corporation (GERN)vs › | $776.24M | -29.28% | -127.46% | -26333.62% | -23986.43% |
| Design Therapeutics, Inc. (DSGN)vs › | $775.72M | 0.00% | 0.00% | 0.00% | 0.00% |
| Cytek Biosciences, Inc. (CTKB)vs › | $786.48M | -21.60% | -15.14% | -11.45% | -3.99% |
| Attovia Therapeutics, Inc. (ATTO)vs › | $774.32M | -4974.74% | -2487.37% | -2487.37% | -2487.37% |
| Avalo Therapeutics, Inc. (AVTX)vs › | $767.46M | -123601.69% | -69568.65% | -35191.57% | -23714.64% |
| InMode Ltd. (INMD)vs › | $812.20M | 18.47% | 25.77% | 33.72% | 36.17% |
| Candel Therapeutics, Inc. (CADL)vs › | $749.55M | 0.00% | 0.00% | -6934.80% | -9894.67% |
| Gyre Therapeutics, Inc. (GYRE)vs › | $819.44M | 9.86% | 12.61% | -6.26% | -239.99% |
| Anteris Technologies Global Corp. (AVR)vs › | $734.10M | -4908.21% | -3903.83% | -2635.01% | -1845.37% |
Gross Margin
10.4%
Operating Margin
-0.3%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -18.61% |
| 2026-04-10 | 0.84% |
| 2025-12-31 | 6.42% |
| 2025-09-30 | 11.14% |
| 2025-06-30 | 13.39% |
| 2025-03-31 | 3.99% |
| 2024-12-31 | 11.40% |
| 2024-09-30 | 10.62% |
| 2024-06-30 | 8.75% |
| 2024-03-31 | 8.51% |
| 2023-12-31 | -14.75% |
| 2023-09-30 | -78.99% |
| 2023-06-30 | 9.30% |
| 2023-03-31 | 3.52% |
| 2022-12-31 | 1.97% |
| 2022-09-30 | 9.49% |
| 2022-06-30 | 11.14% |
| 2022-03-31 | 9.83% |
| 2021-12-31 | 9.84% |
| 2021-09-30 | 16.01% |
| 2021-06-30 | 10.60% |
| 2021-03-31 | 3.20% |
| 2020-12-31 | 9.27% |
| 2020-09-30 | 4.66% |
| 2020-06-30 | 6.71% |
| 2020-03-31 | 4.29% |
| 2019-12-31 | 0.48% |
| 2019-09-30 | -0.91% |
| 2019-06-30 | -1.49% |
| 2019-03-31 | -0.29% |
| 2018-12-31 | -0.44% |
| 2018-09-30 | -0.44% |
| 2018-06-30 | -0.35% |
| 2018-03-31 | -0.11% |
